Back to Results
First PageMeta Content
Pharmaceutical sciences / Health / Pharmacology / Design of experiments / Good Clinical Practice / Regulatory requirement / Clinical trial / Institutional review board / Pre-clinical development / Clinical research / Research / Pharmaceutical industry


Microsoft PowerPoint - h-1- Approach to the Critique of High RiskCT.ppt
Add to Reading List

Document Date: 2012-06-22 04:06:52

Open Document

File Size: 490,73 KB

Share Result on Facebook

City

Helsinki / BANGKOK / /

Company

CASE / /

Country

Canada / /

Event

FDA Phase / /

IndustryTerm

drug substance/product / pharmaceuticals / biotechnology / manufacturing practice / drug product / investigational product / /

MedicalCondition

disease / hypersensitivity / /

MedicalTreatment

gene therapy / immunosuppression / /

Organization

Health Products and Food Branch / Genetic Therapies Directorate / /

Person

Pharmacodynamics Pharmacokinetics / Trials Norman Viner / Pierre Trudeau / Norman Viner / Pharmacodynamics Pharmacokinetics Safety / /

Position

qualified physician / representative / qualified dentist / General / animal model / /

Product

Franklin / OF DRUG / /

Technology

gene therapy / Pharmacogenomic / approved protocol / DRUG DEVELOPMENT / biotechnology / /

SocialTag